Irish Medicines Board Drug Safety Newsletter - Drug Safety – January 2002 - Issue No.14 The Pharmacovigilance Unit, Irish Medicines Board,Earlsford Centre, Earlsford Terrace, Dublin2.
Tel: 676 4971-7 Fax: 676 7836

Levofloxacin (Tavanic) “ The Company responsible for marketing the above product in Ireland have agreed to undertake an epidemiological study to further investigate the risks associated with development of tendon disorders.”
 

NOTE: We have not heard anything further about this study that was to be done overseas or whether it has been completed or made public even though this was announced over three years ago.